Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 601–700 of 1,000
Dhuppar, S., & Mazumder, A. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1482136 · Cited by 19
Ganesan, S., & Keating, A. F. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.008 · Cited by 19
“Decreased p53 prior to follicle loss could be due to interaction of p53 with mdm2, resulting in p53 inhibition (Lakin and Jackson, 1999).”
BackgroundLee, Y., Wan, J., Kim, B.-J., Bae, M., & Song, B. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096719 · Cited by 20
“p53 protein is a transcription factor that plays a critical role in regulating cell growth, DNA repair, and apoptosis in response to stressful conditions (Lakin and Jackson, 1999; Vogelstein et al., 2000).”
BackgroundInfluentialNag, S., Manna, K., & Saha, K. D. (2019) · RSC Advances · doi:10.1039/c9ra00808j · Cited by 18
Reduced Retinal Degeneration in an Oxidative Stress Organ Culture Model through an iNOS-Inhibitor
Mueller‐Buehl, A. M., Tsai, T., Hurst, J., Theiß, C., Peters, L., Hofmann, L., Herms, F., Kuehn, S., Schnichels, S., & Joachim, S. C. (2021) · Biology · doi:10.3390/biology10050383 · Cited by 18
“addition, p53 is activated in the degenerative state of the cell, which in turn induces the transcription of genes that subsequently code for pro-apoptotic proteins such as Bax [43].”
BackgroundRadioprotection by Podophyllum hexandrum in the liver of mice: A mechanistic approach
Kumar, R., Singh, P. K., Arora, R., Sharma, A. K., Prasad, J., Sagar, R., Singh, S., & Sharma, R. K. (2005) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2005.03.008 · Cited by 18
“…along with enhance xpression of HSP-70 in the mice treated with INM-2 n combination with radiation (Figs.1 and 2b) suggeste a functional interaction between HSP-70 and p53, as has been reported in co-immunoprecipitation studies (Diang et al., 1998; Shimizu et al., 1999; Lakin and Jackson, 1999).”
ResultIdentification of genotoxic stress in human cells by fluorescent monitoring of p53 expression
Quiñones, A., & Rainov, N. G. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00179-6 · Cited by 19
Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53
Li, Z., Tu, M., Han, B., Gu, Y., Xue, X., Sun, J., Ge, Q., Miao, Y., Qian, Z., & Gao, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090358 · Cited by 18
“But, how VASH2 influences the sensitivity of CDDP? Given that CDDP induces cell death by forming various adducts with DNA and activates the p53 pathway [21–24].”
BackgroundAshour, F., Awwad, M. H., ELSharawy, H., & Kamal, M. (2018) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2018.04.002 · Cited by 17
Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation
Dacus, D., & Wallace, N. A. (2021) · Viruses · doi:10.3390/v13081662 · Cited by 17
SPINDOC binds PARP1 to facilitate PARylation
Yang, F., Chen, J., Liu, B., Gao, G., Sebastian, M. M., Jeter, C. R., Shen, J., Person, M. D., & Bedford, M. T. (2021) · Nature Communications · doi:10.1038/s41467-021-26588-y · Cited by 19
SMPDL3b modulates radiation‐induced DNA damage response in renal podocytes
Francis, M., Ahmad, A., Bodgi, L., Azzam, P., Youssef, T., Daher, A. A., Eid, A. A., Fornoni, A., Pollack, A. S., Marples, B., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202100186rr · Cited by 17
Zhou, Y., Wei, L., Zhang, H., Dai, Q., Li, Z., Yu, B., Guo, Q., & Lu, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25118 · Cited by 17
RetractedLoignon, M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.35 · Cited by 17
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer
Zhang, B., Wang, E., Dai, H., Hu, R., Liang, Y., Li, K., Wang, G., Peng, G., & Lin, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt190 · Cited by 18
“More importantly, p53 is stabilized and activated upon exposure to DNA-damaging agents or oncogene activation by a series of post-translational modifications that free it from MDM2, resulting in cell cycle arrest, senescence or cell death (46,47).”
BackgroundJin, E., Wang, W., Fang, M., Wang, L., Wu, K., Zhang, Y., Zhang, S., & Ma, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7343 · Cited by 18
“When DNA damage is irreparable, p53 is able to induce cell apoptosis (18,19).”
BackgroundKuusk, A., Neves, J. F., Bravo‐Rodriguez, K., Gunnarsson, A., Ruiz‐Blanco, Y. B., Ehrmann, M., Chen, H., Landrieu, I., Sánchez‐García, E., Boyd, H., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00893 · Cited by 18
Jaks, V., Jõers, A., Kristjuhan, A., & Maimets, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204232 · Cited by 18
“Several post-translational modi®cations of the protein are involved in this process (see May and May, 1999; Lakin and Jackson, 1999 for recent reviews).”
BackgroundTaylor, E. R., Boner, W., Dornan, E. S., Corr, E. M., & Morgan, I. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206746 · Cited by 17
“Repression of E2 transactivation function is p53 independent Stability and turnover of p53 is altered in response to DNA-damaging agents (Lakin and Jackson, 1999), and p53 can associate with E2, making p53 an ideal candidate for mediating repression of E2 transactivation function in response to UVB.”
BackgroundATM: Sounding the Double-strand Break Alarm
Shiloh, Y. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.527 · Cited by 19
Status of CHEK2 and p53 in patients with early‑onset and conventional gastric cancer
Machlowska, J., Kapusta, P., Szlendak, M., Bogdali, A. M., Morsink, F. H. M., Wołkow, P. P., Maciejewski, R., Offerhaus, G. J. A., & Sitarz, R. (2021) · Oncology Letters · doi:10.3892/ol.2021.12609 · Cited by 18
“However, if the cells are arrested at this checkpoint for a sufficient amount of time, the cell may instead undergo apoptosis (22).”
BackgroundMcLean, T. D., Duchi, S., & Bella, C. D. (2022) · Targeted Oncology · doi:10.1007/s11523-022-00876-z · Cited by 18
“e The tumour suppressor genes RB1, CDKN2A and TP53 inhibit cell proliferation by arresting cells in the G1 phase of the cell cycle, with the latter protein being upregulated in response to DNA damage [53, 55].”
BackgroundTargeting NKG2D/NKG2DL axis in multiple myeloma therapy
Liu, Z., Wang, H., Liu, H., Ding, K., Shen, H., Zhao, X., & Fu, R. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.02.001 · Cited by 16
Takemura, Y., Satoh, M., Hatanaka, K., & Kubota, S. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1459466 · Cited by 18
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells
Napolitano, R., Matteis, S. D., Carloni, S., Bruno, S., Abbati, G., Capelli, L., Ghetti, M., Bochicchio, A. M., Liverani, C., Mercatali, L., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7730 · Cited by 16
“Under stress conditions, p53 is phosphorylated by various sensor kinases, promoting the dissociation of the p53-MDM2 complex and p53 stabilization and activation (16,17).”
BackgroundRetractedXu, Q., Zhang, Z., Tang, M., Xing, C., Chen, H., Zheng, K., Zhao, Z., Zhou, S., Zhao, A. Z., Li, F., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.005 · Cited by 18
Antitumor agents 248. Chemistry and antitumor activity of tylophorinerelated alkaloids
Wei, L., Brossi, A. R., Morris-Natschke, S. L., Bastow, K. F., & Lee, K. (2008) · Studies in natural products chemistry · doi:10.1016/s1572-5995(08)80023-3 · Cited by 16
Low Energy Proton Beam Induces Efficient Cell Killing in A549 Lung Adenocarcinoma Cells
Ghosh, S., Bhat, N. N., Santra, S., Thomas, R. G., Gupta, S., Choudhury, R. K. R., & Krishna, M. (2010) · Cancer Investigation · doi:10.3109/07357901003630991 · Cited by 18
“These, in turn, phosphorylate target proteins such as p53, Cdc25A, and Cdc25C (25) to delay the cell cycle, a process called the DNA damage checkpoint.”
BackgroundKwak, J., Tiwari, I., & Jang, K. L. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000655 · Cited by 16
Breitenbach, T., Liang, C., Beyersdorf, N., & Dandekar, T. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007075 · Cited by 16
Tomicic, M. T., Christmann, M., & Kaina, B. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1392-3 · Cited by 17
Inhibitors of topoisomerases as anticancer drugs: problems and prospects.
Dwarakanath, B. S. R., Khaitan, D., & Mathur, R. (2004) · PubMed · Cited by 16
Liu, Y., Ma, C., Li, H., Li, L., Gao, F., & Ao, C. (2016) · Theriogenology · doi:10.1016/j.theriogenology.2016.11.030 · Cited by 16
Ogunnaike, B. A. (2005) · Journal of The Royal Society Interface · doi:10.1098/rsif.2005.0077 · Cited by 16
“…f (t) realized as a rectangular pulse of unit height, duration 250 min (Lahav et al. 2004), passed through a first order filter (time constant 40 min) to smooth out the sharp transitions of the rectangular pulse and yield a more physiologically realistic stress signal (Lakin & Jackson 1999).”
BackgroundInfluentialLee, S. M., Youn, B., Kim, C. S., Kim, C. S., Kang, C., & Kim, J. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13235-3 · Cited by 16
“kr DNA damage caused by IR results in various cellular responses such as cell cycle arrest, tumorigenesis, and apoptosis (Backlund et al., 2001; Gong and Almasan, 2000; Lakin and Jackson, 1999), regulated by both p53-dependent and p53-independent pathways (Khanna and Jackson, 2001; Wahl and Carr, 2001).”
BackgroundEffect of pH on radiation-induced p53 expression
Choi, E. K., Roberts, K. P., Griffin, R. J., Han, T.-H., Park, H.-J., Song, C. W., & Park, H. J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.043 · Cited by 19
Tran, N. K. S., Nguyen, N. Q., Lee, S., Kim, S. H., Jeong, D., Seo, E., Park, J. J., Cho, J., & Kang, K. S. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00956-w · Cited by 15
“Regarding to DNA damage, activation of p53 enhances its DNA-binding ability, leading to cell cycle arrest, apoptosis, or DNA repair [80].”
ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment
Kciuk, M., Gruszka, R., Aleksandrowicz, M., Śliwińska, A., & Kontek, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167709 · Cited by 16
“This topic was previously reviewed by our group [92,93] and others [94–96].”
Kogaki, T., Ohshio, I., Kawaguchi, M., Kimoto, M., Kitae, K., Hase, H., Ueda, Y., Jingushi, K., & Tsujikawa, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.024 · Cited by 15
Stress response of a p53 homologue in the radioresistant Sf9 insect cells
Suman, S., Khaitan, D., Pati, U., Seth, R. K., & Chandna, S. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902748591 · Cited by 15
“…such as DNA damage, increase in protein concentration may be observed in response to stress stimuli due to stabilization of p53 protein (Kastan et al. 1991) resulting from post-translational modifications such as phosphorylation, acetylation, ribosylation and sumoylation (Lakin and Jackson 1999).”
BackgroundAlqaryyan, M., Kilarkaje, N., Mouihate, A., & Al‐Bader, M. (2016) · Reproductive Sciences · doi:10.1177/1933719116681518 · Cited by 15
“The tumor suppressor, p53, controls cell cycle checkpoints meant for DNA damage repair, but if the damage is overwhelming, then it initiates apoptosis.(24,26) p21 is a downstream target of p53, which is involved in cell cycle arrest at G1/S transition in response to DNA damage, interferes with PCNA functions, and inhi…”
BackgroundThe apoptotic effect of oral administration of microcystin‐RR on mice liver
Huang, P., Zheng, Q., & Xu, L. (2011) · Environmental Toxicology · doi:10.1002/tox.20570 · Cited by 17
Genetic basis and gene therapy trials for thyroid cancer.
Al‐Humadi, H., Ζάρρος, Α., Al‐Saigh, R., & Liapi, C. A. (2010) · PubMed · Cited by 19
Nango, R., Terada, C., & Tsukamoto, I. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01764-3 · Cited by 15
MicroRNA‑10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells
Lin, C., Liao, W., Yang, T., Lu, H., Hsu, S., & Wu, C. (2021) · Oncology Reports · doi:10.3892/or.2021.8118 · Cited by 14
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
Khazaei, S., Nilsson, L. H., Adrian, G., Tryggvadottir, H., Konradsson, E., Borgquist, S., Isaksson, K., Ceberg, C. P., & Jernström, H. (2022) · Oncotarget · doi:10.18632/oncotarget.28204 · Cited by 14
“Moreover, γH2AX, one of the most sensitive markers of radiation-induced DNA damage and radiation response [30, 31], p53, which play a role in response to cellular stresses, including DNA damage and cell cycle regulation [32, 33], and cyclin D1, an important regulator of cell cycle and proliferation [34], showed no sig…”
ResultMouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants
Jardí, F., Kelly, C., Teague, C. R., Fowler-Williams, H., Sévin, D. C., Rodrigues, D., Jo, H., Ferreira, S., Herpers, B., van Heerden, M., et al. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03374-3 · Cited by 15
“In all four datasets, URA identified the transcription factor p53, which mediates cell-cycle arrest, apoptosis, and DNA repair upon DNA damage (Lakin and Jackson 1999), as the top activated upstream regulator.”
BackgroundProtein adduction causes non-mutational inhibition of p53 tumor suppressor
Gokulan, R. C., Paulrasu, K., Azfar, J., El-Rifai, W. M., Que, J., Boutaud, O. G., Ban, Y. J., Gao, Z., Buitrago, M. G., Dikalov, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112024 · Cited by 14
“Since p53 is an important regulator of the cell cycle that can induce G1/G0 cell-cycle arrest, 34 we performed the cell-cycle analysis in CP-A treated with ABS.”
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
Im, J., Kang, M., Kim, B., & Won, M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00974-6 · Cited by 16
Loss of p53 function promotes DNA damage-induced formation of nuclear actin filaments
Torii, T., Sugimoto, W., Itoh, K., Kinoshita, N., Gessho, M., Goto, T., Uehara, I., Nakajima, W., Budirahardja, Y., Miyoshi, D., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06310-0 · Cited by 15
“Normally, the activity of p53 is maintained at a low level [31, 32].”
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Kirby, T. J., Zahr, H. C., Fong, E. H. H., & Lammerding, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01998-1 · Cited by 14
“Treatment with nutlin-3 signi fi cantly decreased fractional shortening (i.e., percent of contraction) of the muscle fi bers in response to electrical stimulation, in a nutlin-3 dose-dependent manner (Fig.”
BackgroundGhosh, S., Narang, H., Sarma, A., Kaur, H., & Krishna, M. (2011) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2011.05.002 · Cited by 15
Ghosh, P., Bhoumik, A., Saha, S., Mukherjee, S., Azmi, S., Ghosh, J. K., & Dungdung, S. R. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25958 · Cited by 14
“During DNA damage due to apoptosis, the expression of p53 increases (Lakin & Jackson, 1999).”
BackgroundMitkin, N. A., Muratova, A. M., Sharonov, G. V., Korneev, K. V., Sviriaeva, E. N., Mazurov, D. V., Schwartz, A. M., & Kuprash, D. V. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.10.003 · Cited by 16
Kim, S., Kwon, S., Lee, S., & Baek, K. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4302 · Cited by 17
“Cellular stress such as UV exposure induces p53 activation that regulates cell cycle, DNA repair, and apoptosis (33).”
Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
Singh, S., Raina, V., Chavali, P. L., Dubash, T. D., Sreenath, K., Parab, P. B., & Chattopadhyay, S. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-28 · Cited by 14
“The tumor suppressor protein p53 can cause cell cycle arrest upon DNA damage induced activation [24-30].”
BackgroundDoi, K. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.695 · Cited by 15
“…after treatment with DNA-damaging agents (Nam et al., 2010). p53 is known as a “guardian of genome”, and plays a critical role in DNA repair, cell cycle arrest, and apoptosis in response to DNA damage (Morrison et al., 1996; Uberti et al., 1998; Lakin and Jackson, 1999; Katayama et al., 2001).”
BackgroundDowell, J. D., Tsai, S.-C., Dias-Santagata, D. C., Nakajima, H., Wang, Z., Zhu, W., & Field, L. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.020 · Cited by 14
p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen
Aizu, W., Guda, K., Nambiar, P., Xin, T., Thibodeau, M., Rosenberg, D. W., & Giardina, C. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00221-2 · Cited by 16
James, L. R., Le, C., & Scholey, J. W. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00232.2009 · Cited by 13
“To further explore link(s) between flux through the hexosamine pathway and apoptosis in MC, we studied the effect of glucosamine (10 mM) on the expression of the proapoptotic proteins, p53 (27), and Bax, and the anti-apoptotic protein, Bcl-2 (46), by Western blot analysis (Fig.”
BackgroundTan, G., Uson‐Lopez, R. A., Rahman, M. M., Hosokawa, T., Saito, T., & Kurasaki, M. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.12.016 · Cited by 13
A mouse model of human oral-esophageal cancer
Opitz, O. G., Harada, H., Suliman, Y., Rhoades, B., Sharpless, N. E., Kent, R., Kopelovich, L., Nakagawa, H., & Rustgi, A. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215324 · Cited by 35
Arnould, S., Spanswick, V. J., Macpherson, J. S., Hartley, J. A., Thurston, D. E., Jodrell, D. I., & Guichard, S. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0018 · Cited by 14
“NH2-terminal modifications of p53 in response to DNA damage inhibit its interaction with Mdm2, increasing the protein levels and its transcriptional activity (19).”
BackgroundGenotoxic effects of food contact recycled paperboard extracts on two human hepatic cell lines
Souton, E., Séverin, I., Hégarat, L. L., Hogeveen, K. N., Aljawish, A., Fessard, V., & Chagnon, M. (2017) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2017.1397774 · Cited by 13
Henriksson, G., Brant, M., Sallmyr, A., Fukushima, S., Manthorpe, R., & Bredberg, A. C. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00997.x · Cited by 13
“Under normal cell growth conditions p53 is present in very low amounts because of its extremely short protein half-life, which is required for it to stabilize in response to DNA damage [ 17 ].”
BackgroundDesai, N., Wu, H., George, K. A., Gonda, S. R., & Cucinotta, F. A. (2004) · Advances in Space Research · doi:10.1016/j.asr.2004.01.011 · Cited by 13
Francis, M. A., & Rainbow, A. J. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720554ueeoar2.0.co2 · Cited by 17
p53 blocks RuvAB promoted branch migration and modulates resolution of Holliday junctions by RuvC
Prabhu, V., Simons, A. M., Iwasaki, H., Gai, D., Simmons, D. T., & Chen, J. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5408 · Cited by 13
Efeitos da luz UVA em células de pacientes com Xeroderma Pigmentosum Variante
Moreno, N. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2018.tde-22012018-162542 · Cited by 13
Kamal, M. J., Joanisse, S., & Parise, G. (2023) · GeroScience · doi:10.1007/s11357-023-00929-9 · Cited by 14
“It is possible that p53 was transiently expressed in order to activate p21 expression prior to the 1-h time point [59].”
Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats
Hassan, R., Othman, N., Mansor, S. M., Müller, C. P., & Hassan, Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.018 · Cited by 12
Liu, P., Fu, W., Verwilst, P., Won, M., Shin, J. W., Cai, Z., Tong, B., Shi, J., Dong, Y., & Kim, J. S. (2020) · Angewandte Chemie · doi:10.1002/ange.201916524 · Cited by 12
Lucchesi, C. A., Zhang, J., Gao, M., Shaw, J. T., & Chen, X. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0627 · Cited by 12
Charkiewicz, R., Sulewska, A., Mróz, R. M., Charkiewicz, A., Naumnik, W., Kraska, M., Gyenesei, A., Gálik, B., Junttila, S., Miskiewicz, B., et al. (2023) · Cancers · doi:10.3390/cancers15204910 · Cited by 13
“The p53 pathway is a significant tumor suppressor pathway that mediates DNA damage response and apoptosis in cancer cells [83].”
Thayyullathil, F., Chathoth, S., Kizhakkayil, J., Galadari, A., Hago, A., Patel, M. C., & Galadari, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.156 · Cited by 12
Compensated pathogenic deviations
Barešić, A., & Martin, A. C. R. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.025 · Cited by 15
“p53 is a tumor suppressor protein which plays a central role in detecting DNA damage, slowing the cell cycle to allow DNA repair enzymes to do their work (49), or if DNA damage is too severe, triggering programmed cell death (apoptosis) (50, 51).”
BackgroundSifford, J. M., Stahl, J. A., Salinas, E., & Forrest, J. C. (2015) · Journal of Virology · doi:10.1128/jvi.02867-15 · Cited by 13
“In contrast to mock-infected controls, cells infected with MHV68 exhibited ATM phosphorylation on S1981, Chk2 mobility shift indicative of hyperphosphorylation, and p53 stabilization and phosphorylation on S18, which is a well-characterized residue targeted by ATM for phosphorylation (46, 47) (Fig.”
BackgroundMolecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
Min‐Wen, J. C., Chua, B. Y.-J., Mishra, S., Dai, X., Magae, J., Shyh‐Chang, N., Kumar, A. P., & Sethi, G. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.001 · Cited by 12
“Under stressful conditions such as oxidative stress and the damage of the DNA, p53 will be activated within minutes (Lakin & Jackson, 1999).”
BackgroundECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage
Patel, H., Sheikh, M. S., & Huang, Y. K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2728-1 · Cited by 12
Ethanol‐induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome
Cerretelli, G., Zhou, Y. Y., Müller, M. F., Adams, D. J., & Arends, M. J. (2021) · The Journal of Pathology · doi:10.1002/path.5796 · Cited by 12
“The presence of DNA damage induces p53 pathway activation that can be demonstrated immunohistochemically as a greater proportion of cells containing moderate to high (but variable) nuclear staining of p53 in individual cells (‘wild-type pattern’, distinguishable from the mutated p53-associated ‘overexpression’ or ‘com…”
BackgroundNovel DNA Polymerases and Novel Genotoxicity Assays
Nohmi, T. (2007) · Genes and Environment · doi:10.3123/jemsge.29.75 · Cited by 12
Cui, W., Yazlovitskaya, E. M., Mayo, M. S., Pelling, J. C., & Persons, D. L. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200012)29:4<219::aid-mc1004>3.0.co;2-d · Cited by 76
Narasimhan, M., Rose, R., Muthusamy, K., & Rathinavelu, A. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.029 · Cited by 12
Wang, W., Meng, F., Wang, Z., Li, X., & Zhou, D. (2018) · Cell Biology International · doi:10.1002/cbin.10934 · Cited by 14
“…downstream genes transcription, which all function in all kinds of cellular responses, including proapoptotic molecular (FAS, PUMA, BAX, and p21) and prosurvival factors (Bcl-2 and Bcl-xl) (Shieh et al., 1997; Lakin and Jackson, 1999; Haupt et al., 2003; Macip et al., 2003; Hofseth et al., 2004).”
BackgroundJiang, W., Zhu, Z., Ganther, H. E., Ip, C., & Thompson, H. J. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00647-9 · Cited by 12
Tomas, F., Roux, P., & Gire, V. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07213-4 · Cited by 12
“The transcription factor p53 regulates cell fate decisions in response to cellular stress [1].”
Cheng, H., Tang, S., Lian, X., Hong, M., Gu, X. Q., Jiang, J., & Li, X. (2021) · Journal of Cancer · doi:10.7150/jca.56709 · Cited by 11
“The p53, a classic tumor suppressor gene, plays an important role in cell biology including cell cycle process, DNA repair, senescence, and induction of ferroptosis and apoptosis [11, 12].”
BackgroundAnti-tumor effect of Cordyceps militaris in HCV-infected human hepatocarcinoma 7.5 cells
Lee, S., Lee, H. H., Kim, J., Jung, J., Moon, A., Jeong, C., Kang, H., & Cho, H. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-5198-x · Cited by 11
“…for the development of anti-HCV drugs (Wakita et al., 2005; Binder et al., 2007). p53 stimulates cellular apoptosis in response to DNA damage, which is actually mediated by the activation of Bax, a member of pro-apoptotic molecules in the Bcl-2 family (Lakin and Jackson, 1999; Wu and Deng, 2002).”
BackgroundHydroxyurea (HU)-induced apoptosis in the mouse fetal lung
Woo, G., Bak, E., Nakayama, H., & Doi, K. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.02.007 · Cited by 11
RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner
Parvathaneni, S., Lu, X., Chaudhary, R., Lal, A., Madhusudan, S., & Sharma, S. (2017) · Oncotarget · doi:10.18632/oncotarget.18237 · Cited by 11
Yang, T., Teng, C. J., Lin, T., Chen, K., Hsu, S., & Wu, C. (2017) · International Journal of Cancer · doi:10.1002/ijc.31035 · Cited by 11
“The p53 is known to act biochemically as a nuclear transcription factor which can be activated in response to DNA damage, hypoxia, and abnormal expression of oncogenes.(18,19) The transcriptional targets induced by activated p53 include p21, GADD45, Fas, Puma and Bax, which are involved in arresting cell cycle or indu…”
BackgroundEthanol-induced DNA repair in neural stem cells is transforming growth factor β1-dependent
Hicks, S. D., & Miller, M. W. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.003 · Cited by 11
Liang, M., Li, H., Wang, Z., Cai, L., & Yang, L. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9888 · Cited by 11
Celastrol-mediated autophagy regulation in cancer
Haroon, M., & Kang, S. C. (2020) · Applied Biological Chemistry · doi:10.1186/s13765-020-00565-3 · Cited by 11
Rajput, M., Mishra, D., Kumar, K., & Singh, R. P. (2022) · Journal of Cancer Prevention · doi:10.15430/jcp.2022.27.3.170 · Cited by 11
“The activation of p53 protein in response to IR-induced DNA damage increases its transcriptional activity for various genes involved in DNA repair, cell cycle arrest and apoptosis [34-36].”
BackgroundAbnormal stability of wild-type p53 protein in a human lung carcinoma cell line
Yamauchi, M., Suzuki, K., Kodama, S., & Watanabe, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.174 · Cited by 11
Mechanisms of p53 activation and physiological relevance in the developing kidney
Aboudehen, K., Hilliard, S. A., Saifudeen, Z. R., & El-Dahr, S. S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00642.2011 · Cited by 12
“Importantly, we found that the p53 modification cassette during normal kidney development resembles the one elicited during the p53 response to DNA damage (10, 19, 21, 29, 37).”
BackgroundKwak, J., Choi, J., & Jang, K. L. (2017) · Oncotarget · doi:10.18632/oncotarget.20337 · Cited by 11
“com/oncotarget Ser-15 or the Ser-20 residue is known to increase its protein stability [28]; therefore, it is likely that HCV Core upregulates p53 by activating the ATM-CHK2 pathway in the absence of ATRA.”
BackgroundPost-Translational Regulation of the RSF1 Chromatin Remodeler under DNA Damage.
Min, S., Choi, Y. W., Yun, H., Jo, S.-J., Ji, J., & Cho, H. (2018) · PubMed Central · doi:10.14348/molcells.2018.2244 · Cited by 11
“…homeostasis for maintaining protein levels is usually important for signal transduction, particularly in DDR. p53 is the most well-known tightly regulated protein in response to DNA damage, and its post-transcriptional modification is highly important for its stability (Lakin and Jackson, 1999).”
Background
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.